Ultragenyx Pharmaceutical
RARE
#3808
Rank
A$4.90 B
Marketcap
A$50.80
Share price
-1.78%
Change (1 day)
-27.68%
Change (1 year)

Market capitalization of Ultragenyx Pharmaceutical (RARE)

Market cap: A$4.90 Billion

As of December 2025 Ultragenyx Pharmaceutical has a market cap of A$4.90 Billion. This makes Ultragenyx Pharmaceutical the world's 3808th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ultragenyx Pharmaceutical from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025A$4.90 B-23.97%
2024A$6.44 B11.85%
2023A$5.76 B20.76%
2022A$4.77 B-39.63%
2021A$7.90 B-33.62%
2020A$11.91 B237.56%
2019A$3.52 B12.4%
2018A$3.13 B24.07%
2017A$2.53 B-36.52%
2016A$3.98 B-33.44%
2015A$5.98 B249.69%
2014A$1.71 B

End of Day market cap according to different sources

On Dec 23rd, 2025 the market cap of Ultragenyx Pharmaceutical was reported to be:

A$4.90 Billion
by Nasdaq info icon info icon
A$4.90 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
BioMarin Pharmaceutical
BMRN
A$17.48 B 256.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A$6.54 B 33.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$1.36 B-72.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
A$0.65 B-86.65%๐Ÿ‡บ๐Ÿ‡ธ USA